Guideline for anti-TNF-alpha therapy in psoriatic arthritis (Q36032569)

11 August 2017

1 reference

title

Guideline for anti-TNF-alpha therapy in psoriatic arthritis (English)

1 reference

11 August 2017

0 references

Christopher Griffiths

3

object named as

C E M Griffiths

1 reference

11 August 2017

D Symmons

8

0 references

Iain McInnes

object named as

I McInnes

6

0 references

Philip Helliwell

4

object named as

P Helliwell

0 references

author name string

S Kyle

1

1 reference

11 August 2017

D Chandler

2

1 reference

11 August 2017

J Lewis

5

1 reference

11 August 2017

S Oliver

7

1 reference

11 August 2017

N McHugh

9

1 reference

11 August 2017

British Society for Rheumatology Standards Guidelines Audit Working Group (SGAWG)

10

1 reference

11 August 2017

3 February 2005

1 reference

11 August 2017

1 reference

11 August 2017

44

1 reference

11 August 2017

3

1 reference

11 August 2017

390-397

1 reference

Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?

11 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Efficacy of infliximab in psoriatic arthritis resistant to treatment with disease modifying antirheumatic drugs: an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Articular manifestations of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Assessment of patients with psoriatic arthritis: a review of currently available measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Assessment of enthesitis in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH514

10.1093/RHEUMATOLOGY/KEH514

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference